Targeted Forceps Biopsy for Colorectal Tumors
Concordance Rate of Pathology Between Targeted Forceps Biopsy and Resected Specimen for Large Colorectal Tumors
1 other identifier
interventional
64
1 country
1
Brief Summary
This study evaluates whether targeted forceps biopsy with careful tumor surface evaluation can improve diagnostic accuracy of colorectal tumors larger than 2 cm during colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 19, 2018
CompletedFirst Posted
Study publicly available on registry
July 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedJuly 27, 2018
July 1, 2018
11 months
July 19, 2018
July 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pathologic diagnosis
The pathologic diagnosis of forceps biopsy is compared with the pathologic diagnosis of resected specimen of the colorectal tumor.
7 days
Study Arms (2)
Targeted forceps biopsy
EXPERIMENTALIn this group, an endoscopist takes a forceps biopsy at depressed mucosa or large nodular area of large colorectal tumors after meticulous surface evaluation.
Conventional forceps biopsy
NO INTERVENTIONIn this group, an endoscopist takes a forceps biopsy at the most convenient area of large colorectal tumors.
Interventions
Forceps biopsy is taken after surface evaluation of the large colorectal tumors.
Eligibility Criteria
You may qualify if:
- Patients with colorectal neoplasms of the size larger than 2 cm
You may not qualify if:
- Patients who deny the participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kyungpook National University Hospital
Daegu, 41944, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 19, 2018
First Posted
July 27, 2018
Study Start
September 1, 2017
Primary Completion
August 1, 2018
Study Completion
October 1, 2018
Last Updated
July 27, 2018
Record last verified: 2018-07